Literature DB >> 12451082

Diagnosis and management of depression in primary care: a clinical update and review.

Ronald A Remick1.   

Abstract

THERE HAS BEEN SIGNIFICANT PROGRESS in the area of mood disorders over the last 2 decades, encompassing advances in our knowledge of epidemiology, diagnosis, pathogenesis and treatment. This article presents a clinically oriented update and review on the diagnosis and management of major depressive disorder.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12451082      PMCID： PMC134138     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


  60 in total

Review 1.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  Incidence of major depression in Canada.

Authors:  S B Patten
Journal:  CMAJ       Date:  2000-09-19       Impact factor: 8.262

Review 3.  The SSRI discontinuation syndrome.

Authors:  P Haddad
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  Affective disorders and suicide risk: a reexamination.

Authors:  J M Bostwick; V S Pankratz
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

5.  The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge.

Authors:  S Misri; D Kostaras; X Kostaras
Journal:  Can J Psychiatry       Date:  2000-04       Impact factor: 4.356

6.  A 40-year perspective on the prevalence of depression: the Stirling County Study.

Authors:  J M Murphy; N M Laird; R R Monson; A M Sobol; A H Leighton
Journal:  Arch Gen Psychiatry       Date:  2000-03

Review 7.  Toward effective early intervention and prevention strategies for major affective disorders: a review of antecedents and risk factors.

Authors:  A Duffy
Journal:  Can J Psychiatry       Date:  2000-05       Impact factor: 4.356

8.  A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

Authors:  M B Keller; J P McCullough; D N Klein; B Arnow; D L Dunner; A J Gelenberg; J C Markowitz; C B Nemeroff; J M Russell; M E Thase; M H Trivedi; J Zajecka
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

9.  Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

Authors:  L L Judd; M J Paulus; P J Schettler; H S Akiskal; J Endicott; A C Leon; J D Maser; T Mueller; D A Solomon; M B Keller
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

10.  Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression.

Authors:  E Frank; V J Grochocinski; C A Spanier; D J Buysse; C R Cherry; P R Houck; D M Stapf; D J Kupfer
Journal:  J Clin Psychiatry       Date:  2000-01       Impact factor: 4.384
View more
  26 in total

1.  The prevalence of depression among patients and its detection by primary health care workers at Matawale Health Centre (Zomba).

Authors:  Michael Udedi
Journal:  Malawi Med J       Date:  2014-06       Impact factor: 0.875

Review 2.  Prescription privileges for psychologists: a comprehensive review and critical analysis of current issues and controversies.

Authors:  Kim L Lavoie; Silvana Barone
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Type 2 diabetes does not increase risk of depression.

Authors:  Lauren C Brown; Sumit R Majumdar; Stephen C Newman; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

Review 4.  Depression among older adults with diabetes mellitus.

Authors:  Mijung Park; Charles F Reynolds
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

5.  Expressing uncertainty in clinical interactions between physicians and older patients: what matters?

Authors:  Ming Tai-Seale; Cheryl Stults; Weimin Zhang; Martha Shumway
Journal:  Patient Educ Couns       Date:  2011-07-20

6.  The relationship between fatigue and light exposure during chemotherapy.

Authors:  Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Sherella Johnson; Mairav Cohen-Zion; Lavinia Fiorentino; Georgia Robins Sadler; Sonia Ancoli-Israel
Journal:  Support Care Cancer       Date:  2005-04-29       Impact factor: 3.603

Review 7.  Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges.

Authors:  Hafsah Akhtar; Faiza Bukhari; Misbah Nazir; Muhammad Nabeel Anwar; Adeeb Shahzad
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

8.  A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice.

Authors:  Alexander V Kulikov; Maria A Tikhonova; Elizabeth A Kulikova; Konstantin P Volcho; Tatyana M Khomenko; Nariman F Salakhutdinov; Nina K Popova
Journal:  Psychopharmacology (Berl)       Date:  2011-11-30       Impact factor: 4.530

Review 9.  Psychogenic movement disorders: diagnosis and management.

Authors:  Madhavi Thomas; Joseph Jankovic
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Nefazodone (Serzone) withdrawn because of hepatotoxicity.

Authors:  Stephen Choi
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.